Evaluation of Cardiac Variability After a Vitamine D Protocol and Whole Body Vibration
NCT ID: NCT03679325
Last Updated: 2018-09-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
59 participants
INTERVENTIONAL
2018-05-20
2018-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vitamin D Supplementation and WBV in Inflammatory Markers, Strength and Body Composition in Old Patients With COPD
NCT03684330
Physical Training and Heart Rate Variability in COPD
NCT01889563
Whole Body Vibration in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT01649310
Continuous Chest Wall Vibration in COPD Rehabilitation
NCT03644888
Vibration Training in Chronic Obstructive Pulmonary Disease (COPD)-Patients During a Three-week Rehabilitation
NCT01380652
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
vitamine D
a dose once a week
vitamine D
a dose once a week
whole body vibration (WBV)
03 months of WBV training three times per week
vitamine D placebo
a dose once a week
whole body vibration (WBV)
03 months of WBV training three times per week
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
vitamine D
a dose once a week
whole body vibration (WBV)
03 months of WBV training three times per week
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI between 22.9 and 28 kg/m2
* COPD with clinical-functional diagnosis of the disease according to Gold
* ex-smokers
Exclusion Criteria
* Who participate in pulmonary rehabilitation programs in the last year
* Who used home oxygen therapy
* Patients with COPD-associated comorbidities
* Who were taking vitamin D
60 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maíra F Pessoa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maíra F Pessoa
Clinical Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Federal University of Pernambuco
Recife, Pernambuco, Brazil
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Williamson A, Martineau AR, Jolliffe D, Sheikh A, Janssens W, Sluyter J, Rafiq R, de Jongh R, Griffiths CJ. Vitamin D for the management of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2024 Sep 27;9(9):CD013284. doi: 10.1002/14651858.CD013284.pub2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COPDcardiac variability
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.